[An autopsy case of rheumatoid arthritis accompanied with acute exacerbation of interstitial pneumonia]. 1998

K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
First Department of Internal Medicine, Nagasaki University School of Medicine.

An autopsy case of rheumatoid arthritis (RA) with acute exacerbation of interstitial pneumonia is reported. A 57-year-old woman with longstanding RA was admitted to our hospital because of progressive dyspnea. On chest roentogenogram, diffuse interstitial shadow was confirmed in both lungs. Chest computed tomography (CT) showed diffuse lesion of elevated density of CT level in both lung. She was diagnosed as an acute exacerbation of interstitial pneumonia, and treated by methylpredonisolone pulse therapy (1,000 mg/day). Although cyclosporin A (2 mg/kg/day) was combined to steroid therapy, she was died of progressive respiratory failure. The histological findings of the lung showed extensive fibrosis with alveolar damage associated with hyaline membranes, edema and hemorrhage in alveolar space.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012131 Respiratory Insufficiency Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed) Acute Hypercapnic Respiratory Failure,Acute Hypoxemic Respiratory Failure,Hypercapnic Acute Respiratory Failure,Hypercapnic Respiratory Failure,Hypoxemic Acute Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Depression,Respiratory Failure,Ventilatory Depression,Depressions, Ventilatory,Failure, Hypercapnic Respiratory,Failure, Hypoxemic Respiratory,Failure, Respiratory,Hypercapnic Respiratory Failures,Hypoxemic Respiratory Failures,Respiratory Failure, Hypercapnic,Respiratory Failure, Hypoxemic,Respiratory Failures
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
February 1993, Kokyu to junkan. Respiration & circulation,
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
January 2023, Respiratory medicine case reports,
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
October 2001, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
September 1990, Journal of UOEH,
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
January 2022, BMC pulmonary medicine,
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
April 2016, BMC research notes,
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
February 1981, Nihon Kyobu Shikkan Gakkai zasshi,
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
December 2023, Internal medicine (Tokyo, Japan),
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
September 2002, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
K Aratake, and K Eguchi, and K Migita, and Y Kawabe, and N Matsuoka, and M Tominaga, and H Nakamura, and K Ichinose, and S Nagataki, and K Toriyama
March 2024, Respirology case reports,
Copied contents to your clipboard!